Article metrics

Download PDFPDF

Extended report
A randomised phase IIb study of mavrilimumab, a novel GM–CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis

 

Online download statistics by month:

Online download statistics by month: February 2017 to October 2020

AbstractFullPdf
Feb 201710174420
Mar 201711916405
Apr 20172438111
May 20170577205
Jun 201769302120
Jul 2017246247105
Aug 201720820984
Sep 2017211211101
Oct 201725625685
Nov 201724324352
Dec 201735035054
Jan 201839239375
Feb 201827926846
Mar 201831130553
Apr 201840941254
May 201820520647
Jun 201818819037
Jul 201815815845
Aug 201828028058
Sep 201818918954
Oct 201823523593
Nov 201825226162
Dec 201819019142
Jan 201920921148
Feb 201925425871
Mar 201916316357
Apr 201917017045
May 201914314048
Jun 201913713756
Jul 201913512549
Aug 201915214746
Sep 201912812135
Oct 201916214557
Nov 201910910530
Dec 201912812043
Jan 202010810647
Feb 202011611044
Mar 202015214746
Apr 202015715071
May 2020958639
Jun 202013513057
Jul 20201089640
Aug 2020696784
Sep 2020696736
Oct 202030327767
Total7896100893524